Acute Coronary Syndrome Clinical Trial
Official title:
Prediction of Vulnerable Plaque Using Coronary CT Angiography and Computational Fluid Dynamic in Acute Coronary Syndrome
The aim of the PVCFD trial is to predict vulnerable plaque confirmed by OCT using coronary CT angiography and computational fluid dynamics in patients with acute coronary syndrome.
Acute coronary syndrome(ACS)mainly includes unstable angina, non-ST-segment elevation
myocardial infarction, and ST-segment elevation myocardial infarction, which is the leading
cause of death around the world. The main pathophysiological feature of ACS is the rupture of
vulnerable plaque, which can be recognized by coronary artery angiography (CAG),
intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Compared with CAG and
IVUS, OCT is the best intravascular imaging technique so far. But all these examinations are
invasive and expensive. Recently, coronary CT angiography derived adverse plaque
characteristics (APC) and hemodynamic forces defined by computational fluid dynamics (CFD)
can reflect plaque vulnerability and hemodynamic forces acting on the plaque, which are
important factors in the progress of the rupture of vulnerable plaque. So, we want to explore
predictive value of coronary CT angiography (CTA)and computational fluid dynamics for
vulnerable plaque in ACS.
The PVCFD trial is a prospective and single center study, patients with ACS will be arranged
to complete coronary CTA before CAG. OCT will be used to detect the characteristics of
coronary atherosclerotic plaques confirmed by CAG. Lipid plaques with fibrous cap thickness
less than 65um, erosion and coronary artery dissection are defined as vulnerable plaque.
Patients will be divided into vulnerable plaque group and stable plaque group according to
this. The coronary CTA images will be screened for APC and CFD analyses at core laboratories
of Shanghai tenth's hospital. Lesions with diameter stenosis (DS) >30% based on coronary CTA
evaluation were included for subsequent APC (low-attenuation plaque, positive remodeling,
napkin-ring sign, and spotty calcification) analysis and hemodynamic forces (FFRCT,ΔFFRCT,
WSS and PWS) defined by CFD. Three prediction models (Model 1: percent diameter stenosis +
lesion length, Model 2: Model 1 + APC, Model 3: Model 2 + hemodynamic force) will be
constructed to identify vulnerable plaque confirmed by OCT.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Recruiting |
NCT05412927 -
AngelMed Guardian® System PMA Post Approval Study
|
||
Completed |
NCT02750579 -
Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?
|
N/A | |
Completed |
NCT04102410 -
Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients
|
N/A | |
Enrolling by invitation |
NCT03342131 -
Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome
|
N/A | |
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Enrolling by invitation |
NCT04676100 -
International CR Registry
|
||
Completed |
NCT03590535 -
5th Generation cTnT in ED ACS
|
||
Recruiting |
NCT05437900 -
INSIGHTFUL-FFR Clinical Trial
|
Phase 4 | |
Completed |
NCT05551429 -
Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
|
||
Terminated |
NCT04316481 -
IDE-ALERTS Continued Access Study
|
N/A | |
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Not yet recruiting |
NCT04852146 -
Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
|
||
Active, not recruiting |
NCT02892903 -
In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes?
|
N/A | |
Not yet recruiting |
NCT02871622 -
BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
|
N/A | |
Completed |
NCT02944123 -
Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
|
Phase 3 | |
Completed |
NCT04077229 -
Piloting Text Messages to Promote Positive Affect and Physical Activity
|
N/A | |
Active, not recruiting |
NCT02922140 -
The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit
|
N/A | |
Completed |
NCT02673437 -
Rivaroxaban ACS Specialist Cohort Event Monitoring Study
|